Core Viewpoint - Zhuozheng Medical (02677) has successfully listed, pricing each share at HKD 59.9, with a total issuance of 4.75 million shares, raising approximately HKD 209 million in net proceeds. The stock has surged by 35.23% to HKD 81 at the time of reporting, with a trading volume of HKD 71.1362 million [1] Company Overview - Zhuozheng Medical is a private healthcare service provider in China, focusing on the mid-to-high-end medical service market, targeting affluent individuals who prefer personalized care [1] - According to Frost & Sullivan, Zhuozheng Medical is the third-largest private mid-to-high-end comprehensive healthcare service provider in China, holding a market share of 2.0% based on projected revenues for 2024 [1] Service Model - The company adopts a holistic medical approach, integrating both physical and online healthcare services through a family medical model [1] - Zhuozheng Medical offers a range of specialties including pediatrics, dentistry, ophthalmology, dermatology, ENT, surgery, gynecology, and internal medicine, facilitating close collaboration among specialists to meet diverse medical needs of patients and their families [1] - This integrated approach aims to enhance patient satisfaction and create opportunities for cross-specialty referrals [1]
新股首日 | 卓正医疗(02677)首挂上市 早盘高开35.23% 公司专注服务中高端医疗服务市场